Royalty Pharma
RPRX
#844
Rank
NZ$49.50 B
Marketcap
NZ$83.52
Share price
-0.52%
Change (1 day)
54.64%
Change (1 year)

Market capitalization of Royalty Pharma (RPRX)

Market cap: NZ$49.50 Billion

As of April 2026 Royalty Pharma has a market cap of NZ$49.50 Billion. This makes Royalty Pharma the world's 844th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Royalty Pharma from 2020 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$49.50 B25.37%
2025NZ$39.49 B48.01%
2024NZ$26.68 B0.19%
2023NZ$26.63 B-3%
2022NZ$27.45 B9.57%
2021NZ$25.05 B-6.93%
2020NZ$26.92 B

End of Day market cap according to different sources

On Apr 26th, 2026 the market cap of Royalty Pharma was reported to be:

NZ$48.18 Billion
by Nasdaq info icon info icon
NZ$49.50 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Abbott Laboratories
ABT
NZ$267.82 B 440.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$1.335 T 2,597.65%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
NZ$3.02 B-93.89%๐Ÿ‡บ๐Ÿ‡ธ USA